June 3, 2026 · Journal of the Academy of Consultation-Liaison Psychiatry · DOI: 10.1016/j.jaclp.2026.05.005

Clinical Utility and Impact of Phosphatidylethanol (PEth) Testing in Patients Pursuing Kidney Transplantation

Listen to this summary

The authors aimed to evaluate the clinical utility of Phosphatidylethanol (PEth) testing in kidney transplant candidates, particularly its effectiveness in detecting alcohol use compared to traditional methods. Their findings indicate that PEth testing significantly enhances the identification of alcohol use disorders, revealing discrepancies in self-reported alcohol consumption and influencing clinical decisions regarding transplant listing and treatment recommendations. The study suggests that routine PEth screening could improve outcomes by better identifying at-risk patients and guiding interventions.

Matthew Gish, Rachel Meyer, Hannah Bostwick, Drew Fellenz, Jennifer Gifford, Victor Nettey, Laura Priorello, Shirshendu Sinha, Adriana Vasquez, Byron Smith, Carrie Schinstock, David C Fipps

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play